Business Description
G&E Herbal Biotechnology Co Ltd
NAICS : 325411
SIC : 2833
ISIN : TW0004911003
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 57.62 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.05 | |||||
Interest Coverage | 20171 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 17.39 | |||||
Beneish M-Score | 4.13 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 85.9 | |||||
3-Year Book Growth Rate | 2.8 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.02 | |||||
9-Day RSI | 54.35 | |||||
14-Day RSI | 53.27 | |||||
6-1 Month Momentum % | 7.53 | |||||
12-1 Month Momentum % | -21.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.97 | |||||
Quick Ratio | 2.78 | |||||
Cash Ratio | 2.64 | |||||
Days Inventory | 238.41 | |||||
Days Sales Outstanding | 15.73 | |||||
Days Payable | 9.97 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.08 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.69 | |||||
Operating Margin % | 44.47 | |||||
Net Margin % | 39.9 | |||||
FCF Margin % | 59.5 | |||||
ROE % | 9.98 | |||||
ROA % | 9.06 | |||||
ROIC % | 10.74 | |||||
ROC (Joel Greenblatt) % | 23.96 | |||||
ROCE % | 12.47 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 45.77 | |||||
PE Ratio without NRI | 45.77 | |||||
Price-to-Owner-Earnings | 36.38 | |||||
PS Ratio | 18.25 | |||||
PB Ratio | 4.34 | |||||
Price-to-Tangible-Book | 5.26 | |||||
Price-to-Free-Cash-Flow | 30.72 | |||||
Price-to-Operating-Cash-Flow | 29.21 | |||||
EV-to-EBIT | 33.2 | |||||
EV-to-EBITDA | 30.09 | |||||
EV-to-Revenue | 16.55 | |||||
EV-to-FCF | 27.52 | |||||
Price-to-Projected-FCF | 3.66 | |||||
Price-to-Median-PS-Value | 0.19 | |||||
Price-to-Graham-Number | 3.27 | |||||
Price-to-Net-Current-Asset-Value | 14.27 | |||||
Price-to-Net-Cash | 17.15 | |||||
Earnings Yield (Greenblatt) % | 3.02 | |||||
FCF Yield % | 3.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
G&E Herbal Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 181.443 | ||
EPS (TTM) (NT$) | 1.3 | ||
Beta | -1.42 | ||
Volatility % | 19.75 | ||
14-Day RSI | 53.27 | ||
14-Day ATR (NT$) | 1.122041 | ||
20-Day SMA (NT$) | 59.675 | ||
12-1 Month Momentum % | -21.36 | ||
52-Week Range (NT$) | 53 - 83.5 | ||
Shares Outstanding (Mil) | 55.66 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
G&E Herbal Biotechnology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
G&E Herbal Biotechnology Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
G&E Herbal Biotechnology Co Ltd Frequently Asked Questions
What is G&E Herbal Biotechnology Co Ltd(ROCO:4911)'s stock price today?
When is next earnings date of G&E Herbal Biotechnology Co Ltd(ROCO:4911)?
Does G&E Herbal Biotechnology Co Ltd(ROCO:4911) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |